Astria Therapeutics, Inc. (ATXS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -32.3M | -36.06M | -34.02M | -17.36M | -27.96M | -16.79M | -19.09M | -30.24M | -14.26M | -10.7M | -13.25M | -10.66M | -10.25M | -10.06M | -12.56M | -6.29M | -7.75M | -7.4M | -8.72M | -8.06M |
| Operating CF Margin % | -4574.36% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -15.48% | -114.75% | -78.16% | 42.58% | -96.14% | -56.98% | -44.07% | -183.55% | -39.12% | -6.31% | -5.53% | -69.65% | -32.26% | -35.96% | -44.09% | 22.02% | 22.27% | 0.88% | -24.71% | -3.75% |
| Net Income | -31.64M | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M | -12M | -11.25M | -15.32M | -9.49M | -7.87M | -7.47M | -170.08M | -8.98M |
| Depreciation & Amortization | 0 | -1.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 4.35M | 3.84M | 3.4M | 3.43M | 3.45M | 2.75M | 2.07M | 1.69M | 0 | 1.22M | 1.07M | 1.16M | 0 | 1.21M | 0 | 0 | 1.01M | 366K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.91M | 1.41M | -752K | -1.08M | -2.78M | -1.56M | -512K | 163K | 159K | 1.44M | 116K | -569K | 48K | 1.27M | 1.46M | 1.36M | 1.4M | -749K | 164.67M | 321K |
| Working Capital Changes | -4.57M | -6.87M | -3.4M | 5.94M | -4.08M | 5.49M | -1.41M | -1.06M | 1.62M | 432K | -3.4M | 2.1M | 545K | -85K | 92K | 1.84M | -1.28M | -199K | -3.67M | 596K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 398K | -2.96M | -625K | 3.04M | -1.06M | 1.48M | -651K | 375K | 309K | -99K | 140K | 0 | -204K | 65K | -627K | 982K | -47K | -1.19M | -1.71M | 136K |
| Cash from Investing | 52.25M | 57.99M | 28.58M | -3.72M | 6.19M | -68.1M | -126.23M | -2.02M | -4K | -57.92M | 194.99M | -135.18M | 1.95M | -6.8M | -27.1M | -39M | 0 | 0 | 26.45M | -20.01M |
| Capital Expenditures | 0 | -590K | 0 | 0 | -20K | -305K | 0 | -16K | -4K | 0 | -5K | -31K | -58K | -2K | 0 | 0 | 0 | 0 | -21K | -10K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135.15K | 0 | 0 | 0 | 0 | 0 | 0 | 6.47M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -135.15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3K | 0 | 0 | 0 | 15.3M | 94K | 141.81M | 87.98M | 110K | 273K | 37K | 120.4M | 24.32M | 0 | 0 | 17K | 6K | 0 | 104.26M | 31K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3K | 0 | 0 | 0 | 1000K | 94K | 1000K | 1000K | 110K | 273K | 0 | 1000K | 1000K | 0 | 0 | 17K | 6K | 0 | 1000K | 31K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 58K | 0 | 4.63M | 0 | 0 | 0 | 37K | 50K | 34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 19.96M | 21.93M | -5.43M | -21.08M | -6.48M | -84.8M | -3.52M | 55.72M | -14.15M | -68.34M | 181.78M | -25.45M | 16.02M | -16.86M | -39.66M | -45.27M | -7.62M | -7.4M | 121.99M | -28.16M |
| Free Cash Flow | -32.3M | -36.65M | -34.02M | -17.36M | -27.98M | -17.1M | -19.09M | -30.25M | -14.26M | -10.7M | -13.26M | -10.7M | -10.31M | -10.06M | -12.56M | -6.29M | -7.75M | -7.4M | -8.74M | -8.07M |
| FCF Margin % | -4574.36% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -15.4% | -114.37% | -78.16% | 42.61% | -96.22% | -59.84% | -44.02% | -182.88% | -38.37% | -6.29% | -5.57% | -70.14% | -33.01% | -35.99% | -43.74% | 22.12% | 22.27% | 1.19% | -25.17% | -3.71% |
| FCF per Share | -0.56 | -0.63 | -0.59 | -0.31 | -0.50 | -0.30 | -0.37 | -0.83 | -0.51 | -0.38 | -0.47 | -0.58 | -0.75 | -0.77 | -0.96 | -0.49 | -0.60 | -1.24 | -2.34 | -2.16 |
| FCF Conversion (FCF/Net Income) | 1.02x | 1.09x | 1.01x | 0.68x | 1.14x | 0.69x | 0.96x | 0.96x | 0.80x | 0.85x | 1.18x | 0.80x | 0.85x | 0.89x | 0.82x | 0.66x | 0.98x | 0.99x | 0.05x | 0.90x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |